Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-29

Clinical Trial Update: Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia [Phase 4]

View source ↗

Summary

Phase 4 trial update on suvorexant for insomnia, focusing on its efficacy for hot flash-associated insomnia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Suvorexant (suvorexant)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Insomnia | Phase 4 | Status: COMPLETED | Results posted: 2021-10-29